Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases

Annals of Oncology

Volumn 21, Issue 9, 2010, Pages 1926-1927

  Ruggeri, E M ^a   Cecere, F L ^b   Moscetti, L ^a   Doni, L ^b   Padalino, D ^a   di costanzo, F ^b  

^a BELCOLLE HOSPITAL   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SUNITINIB; THYROID HORMONE;

ACUTE HEART FAILURE; AGED; ANURIA; ASCITES; ASTHENIA; BONE METASTASIS; CASE REPORT; COMA; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISEASE SEVERITY; DIURESIS; DYSPNEA; FEMALE; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HUMAN; HYPOKINESIA; HYPOTENSION; HYPOTHYROIDISM; JAUNDICE; KIDNEY CARCINOMA; KIDNEY FAILURE; LETTER; LIVER CIRRHOSIS; LUNG METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; OLIGURIA; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOLYSIS; SIDE EFFECT; THROMBOCYTOPENIA; WEAKNESS;

EID: 77956155000     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq395     Document Type: Letter

References (5)

1. Cibeira MT, Mercadal S, Arenillas L et al. Bortezomib-induced rhabdomyolysis in multiple myeloma. Acta Haematol 2006; 116(3): 203-206.
2. Penel N, Blay JY, Adenis A. Imatinib as a possible cause of severe rhabdomyolysis. N Engl J Med 2008; 358(25): 2746-2747.
3. Reinhold U, Hartl C, Hering R et al. Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interferon alfa in malignant melanoma. Lancet 1997; 349(9051): 540-541.
4. Anderlini P, Buzaid AC, Legha SS. Acute rhabdomyolysis after concurrent administration of interleukin-2, interferon-alfa, and chemotherapy for metastatic melanoma. Cancer 1995; 76(4): 678-679.
5. Veeraputhiran M, Sundermeyer M. Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin. Clin Lung Cancer 2008; 9(4): 232-234.